Global Health Trends
This month, Pharmaceutical Executive examines various initiatives that large pharma implement to address needs of global health in developing nations. These programs range from pure philanthropic endeavors to economically sustainable models for local markets. Programs from Merck, Mylan, Novartis and others are highlighted.

We also look at how governments, Foundations such as the Bill and Melinda Gates Foundation, and pharma work together to address the healthcare needs for global populations.

Executive Profile
Ruud Dobber, PhD, President, AstraZeneca US and Executive Vice President, North America, is featured as our executive profile. Dobber has been overseeing North America and the US for over a year, having previously served in similar executive capacities the EU, EMEA, and Asia Pacific. Dobber discusses the challenges associated with the US healthcare system, AstraZeneca’s excitement around its 2018 launches, and the business focus for the number 11 company on our Pharma 50 list.